- Home
- IHT vs ALLR Comparison
IHT vs ALLR Comparison
Compare IHT & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHT
- ALLR
- Stock Information
- Founded
- IHT 1971
- ALLR 2004
- Country
- IHT United States
- ALLR United States
- Employees
- IHT N/A
- ALLR N/A
- Industry
- IHT Investment Bankers/Brokers/Service
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- IHT Finance
- ALLR Health Care
- Exchange
- IHT Nasdaq
- ALLR Nasdaq
- Market Cap
- IHT 18.2M
- ALLR 20.2M
- IPO Year
- IHT N/A
- ALLR N/A
- Fundamental
- Price
- IHT $1.60
- ALLR $1.46
- Analyst Decision
- IHT
- ALLR Strong Buy
- Analyst Count
- IHT 0
- ALLR 1
- Target Price
- IHT N/A
- ALLR $9.25
- AVG Volume (30 Days)
- IHT 84.5K
- ALLR 343.8K
- Earning Date
- IHT 12-15-2025
- ALLR 11-13-2025
- Dividend Yield
- IHT 1.25%
- ALLR N/A
- EPS Growth
- IHT N/A
- ALLR N/A
- EPS
- IHT N/A
- ALLR N/A
- Revenue
- IHT $7,463,789.00
- ALLR N/A
- Revenue This Year
- IHT N/A
- ALLR N/A
- Revenue Next Year
- IHT N/A
- ALLR N/A
- P/E Ratio
- IHT N/A
- ALLR N/A
- Revenue Growth
- IHT N/A
- ALLR N/A
- 52 Week Low
- IHT $1.37
- ALLR $0.61
- 52 Week High
- IHT $4.24
- ALLR $2.35
- Technical
- Relative Strength Index (RSI)
- IHT 46.97
- ALLR 47.29
- Support Level
- IHT $1.38
- ALLR $1.34
- Resistance Level
- IHT $1.89
- ALLR $1.53
- Average True Range (ATR)
- IHT 0.14
- ALLR 0.11
- MACD
- IHT 0.01
- ALLR -0.02
- Stochastic Oscillator
- IHT 44.23
- ALLR 26.09
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.